Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bumetanide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with bumetanide in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(bumetanide)
Trials
(bumetanide)
Recent Studies (post-2010) (bumetanide)
9,1561875522,033150354

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)bumetanide (IC50)
Solute carrier family 12 member 2Homo sapiens (human)0.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garay, RP; Senn, N1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bumetanide

ArticleYear
Regulation of Na+ and K+ contents in rat thymocytes.
    The American journal of physiology, 1989, Volume: 257, Issue:1 Pt 1

    Topics: Animals; Biological Transport; Blood Coagulation Factors; Bumetanide; Dinoprostone; Hypertension; Isoproterenol; Kinetics; Male; Ouabain; Platelet Activating Factor; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Sodium; Sodium Channels; T-Lymphocytes

1989